Clinical Trial Update: Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL

View source ↗

Summary

This clinical trial update discusses long-term progression of patients treated for relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Snippet

Sponsor: Group for Research in Adult Acute Lymphoblastic Leukemia | Conditions: Ph Positive ALL | Status: RECRUITING